EA200700983A1 - Применение андрогенов для снижения вероятности приобретения или лечения старения кожи - Google Patents

Применение андрогенов для снижения вероятности приобретения или лечения старения кожи

Info

Publication number
EA200700983A1
EA200700983A1 EA200700983A EA200700983A EA200700983A1 EA 200700983 A1 EA200700983 A1 EA 200700983A1 EA 200700983 A EA200700983 A EA 200700983A EA 200700983 A EA200700983 A EA 200700983A EA 200700983 A1 EA200700983 A1 EA 200700983A1
Authority
EA
Eurasian Patent Office
Prior art keywords
skin
treating
loss
androgens
purchasing
Prior art date
Application number
EA200700983A
Other languages
English (en)
Inventor
Мохамед Эл-Алфи
Фернанд Лабри
Лаймиэ Аззи
Original Assignee
Эндорешерш, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эндорешерш, Инк. filed Critical Эндорешерш, Инк.
Publication of EA200700983A1 publication Critical patent/EA200700983A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Abstract

Новые способы лечения или снижения вероятности приобретения заболеваний кожи, обусловленных возрастной андрогенной недостаточностью, а именно атрофии кожи, потери коллагена, потери эластических волокон, потери соединительной ткани, целлюлита, и образовании морщин, у восприимчивых теплокровных животных, включая человека, включающие введение андрогена или/и предшественника половых стероидных гормонов. Также раскрыты фармацевтические композиции для доставки активного(ых) ингредиента(ов), применяемые в изобретении.
EA200700983A 2004-11-01 2005-10-31 Применение андрогенов для снижения вероятности приобретения или лечения старения кожи EA200700983A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62411204P 2004-11-01 2004-11-01
PCT/CA2005/001652 WO2006047859A1 (en) 2004-11-01 2005-10-31 Use of androgens to reduce the likelihood of acquiring or to treat skin aging

Publications (1)

Publication Number Publication Date
EA200700983A1 true EA200700983A1 (ru) 2008-04-28

Family

ID=36318842

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200700983A EA200700983A1 (ru) 2004-11-01 2005-10-31 Применение андрогенов для снижения вероятности приобретения или лечения старения кожи

Country Status (20)

Country Link
US (1) US20060178352A1 (ru)
EP (1) EP1807062A4 (ru)
JP (1) JP2008517952A (ru)
KR (1) KR20070073964A (ru)
CN (1) CN101094676A (ru)
AP (1) AP2007003982A0 (ru)
AU (1) AU2005301035A1 (ru)
BR (1) BRPI0517950A (ru)
CA (1) CA2585666A1 (ru)
EA (1) EA200700983A1 (ru)
GE (1) GEP20094833B (ru)
HR (1) HRP20070183A2 (ru)
IL (1) IL182844A0 (ru)
MA (1) MA29220B1 (ru)
MX (1) MX2007005098A (ru)
NO (1) NO20072642L (ru)
RS (1) RS20070185A (ru)
TN (1) TNSN07163A1 (ru)
WO (1) WO2006047859A1 (ru)
ZA (1) ZA200703531B (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106038572A (zh) 2004-10-20 2016-10-26 恩多研究公司 性甾体前体单独或与选择性雌激素受体调节剂联合用于预防和治疗绝经后女性的性功能障碍
EP2012572B1 (en) 2006-06-01 2018-07-04 Panasonic Corporation Brushless motor for washing machine and washing machine having the brushless motor mounted therein
US8268806B2 (en) 2007-08-10 2012-09-18 Endorecherche, Inc. Pharmaceutical compositions
US10076483B2 (en) * 2013-10-15 2018-09-18 Chelac Holding Gmbh Steroid carboxylic acid esters, compositions containing steroid carboxylic acid esters, and use of said compositions in local topical applications for cosmetic or dermatological purposes
JP6444956B2 (ja) * 2015-09-30 2018-12-26 富士フイルム株式会社 経皮吸収用組成物
EP4034129A4 (en) * 2019-09-23 2023-11-01 The Board of Trustees of the Leland Stanford Junior University TREATMENT PROCEDURES FOR GESTATIONAL EXTENSION AND FOR MENSTRUAL OR GESTATIONAL COMPLICATIONS

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL88180C (ru) * 1953-08-26
WO1994016709A2 (en) * 1993-01-19 1994-08-04 Endorecherche Inc. Therapeutic uses and delivery systems of dehydroepiandrosterone
FR2729854A1 (fr) * 1995-01-26 1996-08-02 Oreal Utilisation du sulfate de dehydroepi-androsterone dans une composition cosmetique ou dermatologique
US5736537A (en) * 1995-09-12 1998-04-07 Estee Lauder, Inc. Dehydroep:androsterone sailcylate useful against skin atrophy
US5709878A (en) * 1996-08-02 1998-01-20 Rosenbaum; Jerry Transdermal delivery of dehydroepiandrosterone
US5869090A (en) * 1998-01-20 1999-02-09 Rosenbaum; Jerry Transdermal delivery of dehydroepiandrosterone
ID27922A (id) * 1998-06-11 2001-05-03 Endorech Inc KOMPOSISI FARMASETIKAL DAN PENGGUNAAN DARI ANDROST-5-ENA-3β, 17β-DIOL
US6117446A (en) * 1999-01-26 2000-09-12 Place; Virgil A. Drug dosage unit for buccal administration of steroidal active agents
FR2803750B1 (fr) * 2000-01-17 2004-04-02 Assist Publ Hopitaux De Paris Utilisation par voie orale de la dehydroepiandrosterone, de ses precurseurs biologiques et de ses derives metaboliques comme anti-atrophiant
US20040198706A1 (en) * 2003-03-11 2004-10-07 Carrara Dario Norberto R. Methods and formulations for transdermal or transmucosal application of active agents
US20030027804A1 (en) * 2001-06-27 2003-02-06 Van Der Hoop Roland Gerritsen Therapeutic combinations for the treatment of hormone deficiencies
JP2004002321A (ja) * 2002-03-11 2004-01-08 Takeda Chem Ind Ltd 性ホルモン依存性疾患治療剤
IL157535A0 (en) * 2003-08-21 2004-03-28 Topimed Ltd Preparations for the prevention of skin atrophy

Also Published As

Publication number Publication date
JP2008517952A (ja) 2008-05-29
KR20070073964A (ko) 2007-07-10
WO2006047859A1 (en) 2006-05-11
GEP20094833B (en) 2009-11-25
AP2007003982A0 (en) 2007-06-30
HRP20070183A2 (en) 2007-08-31
NO20072642L (no) 2007-07-30
MA29220B1 (fr) 2008-02-01
TNSN07163A1 (en) 2008-11-21
MX2007005098A (es) 2008-01-16
US20060178352A1 (en) 2006-08-10
CA2585666A1 (en) 2006-05-11
AU2005301035A1 (en) 2006-05-11
RS20070185A (en) 2008-09-29
EP1807062A4 (en) 2009-06-03
EP1807062A1 (en) 2007-07-18
IL182844A0 (en) 2007-09-20
BRPI0517950A (pt) 2008-10-21
CN101094676A (zh) 2007-12-26
ZA200703531B (en) 2008-07-30

Similar Documents

Publication Publication Date Title
DE502005010615D1 (de) Mittel zur behandlung von entzündlichen erkrankungen
EA200700983A1 (ru) Применение андрогенов для снижения вероятности приобретения или лечения старения кожи
EA200971053A1 (ru) Способы лечения кожных язв
AR049518A1 (es) Composicion farmaceutica que comprende un agente siliconado y dos principios activos solubilizados
BR0317747A (pt) Método de tratamento terapêutico concomitante de um indivìduo, composição farmacêutica, kit, uso de um primeiro agente e um segundo agente, e, métodos de prevenir ou tratar uma doença relacionada com amilóide-b, doença de alzheimer e insuficiência cognitiva suave
EA200600750A1 (ru) Трансдермальная фармацевтическая композиция
DOP2000000114A (es) Oxazolidinonas substituidas y su uso
EA201071038A1 (ru) Производные 1-бензил-3-гидроксиметилиндазола и их применение для лечения заболеваний, основанных на экспрессии mcp-1, cx3cr1 и p40
EA200601747A1 (ru) Три(цикло)замещённые амидные соединения
EA200800050A1 (ru) Самобуферирующиеся композиции белков
ATE550015T1 (de) Verfahren und zusammensetzung zur behandlung von rhinitis
NO20050718L (no) Topikal behandling av hudsykdommer
HK1096857A1 (en) Medicamentously targeted local lipolysis
CY1109843T1 (el) Αναλογα της βιταμινης d
ATE488240T1 (de) Mittel zur behanldung von krankheiten zur aufbringung auf das auge
BR112013005673A2 (pt) uso de lipase de ácido lisossomal para tratamento de deficiência de lipase de ácido lisossomal em pacientes
NO20061236L (no) Farmasoytiske sammensetninger og fremgangsmater omfattende kombinasjoner av 2-alkyliden-19-nor-vitamin D derivater og paratyroidhoziiton
MX2010009624A (es) Derivados de 1-bencil-3-hidroximetilindazol y uso de los mismos en el tratamiento de enfermedades basadas en la expresion de mcp-1 y cx3cr1.
NO20055390L (no) Thorium-227 for anvendelse i radioterapi pa mykvevssykdommer
EA200600996A1 (ru) Композиция для полезного воздействия на кожу с использованием ключевых промежуточных продуктов клеточного метаболизма
BRPI0418157A (pt) terapêutica de tumores alogênicos
ATE422892T1 (de) Verwendung von hyaluronsäure zur herstellung von zusammensetzungen zur behandlung rekurrenten aphthen in der mundhöhle
ATE556134T1 (de) Mesenchymstammzellen und verwendungendafür
EA201591793A1 (ru) Лактамные соединения в качестве селективных агонистов ep4-рецепторов для применения при лечении опосредованных ep4 заболеваний и состояний
DE60330888D1 (de) Verwendung von drospirenon zur behandlung von hypertension